June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017

Effectiveness of real-time PCR assessment for varicella-zoster virus-associated keratitis
Author Affiliations & Notes
  • Dai Miyazaki
    Ophthalmology, Tottori University, Yonago, Japan
  • Kodai Inata
    Ophthalmology, Tottori University, Yonago, Japan
  • RYU UOTANI
    Ophthalmology, Tottori University, Yonago, Japan
  • Daisuke Shimizu
    Ophthalmology, Tottori University, Yonago, Japan
  • Atsuko Miyake
    Ophthalmology, Tottori University, Yonago, Japan
  • Yumiko Shimizu
    Ophthalmology, Tottori University, Yonago, Japan
  • Yoshitsugu Inoue
    Ophthalmology, Tottori University, Yonago, Japan
  • Footnotes
    Commercial Relationships   Dai Miyazaki, None; Kodai Inata, None; RYU UOTANI, None; Daisuke Shimizu, None; Atsuko Miyake, None; Yumiko Shimizu, None; Yoshitsugu Inoue, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 2989. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Dai Miyazaki, Kodai Inata, RYU UOTANI, Daisuke Shimizu, Atsuko Miyake, Yumiko Shimizu, Yoshitsugu Inoue;
      Effectiveness of real-time PCR assessment for varicella-zoster virus-associated keratitis. Invest. Ophthalmol. Vis. Sci. 2017;58(8):2989.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose :
Varicella zoster virus (VZV) causes herpes zoster ophthalmicus by reactivation of latent virus, which leads to ocular complications, characterized by keratitis
or iridocyclitis. Although diagnosis is generally made by its acute skin episode, effectiveness of viral genome-based diagnosis for VZV-associated keratitis has remained obscure. We sought to evaluate how real-time PCR of VZV may improve its diagnostic efficacy as well as predict prognosis for better management of chronic and refractory cases.

Methods :
The medical records of 563 consecutive case series with suspected VZV-associated keratitis or infectious keratitis were retrospectively reviewed. All the patient underwent real-time PCR of VZV using corneal scraping samples at the Tottori University Medical Hospital between November 2005 and September 2016. Diagnostic accuracy of real-time PCR and clinical signs were determined by receiver operating characteristic analysis. Prognosis, described as the persistence of active disease and complications, were assessed for their associations using logistic regression and cox proportional hazard model.

Results :
For the VZV-associated keratitis (38 eyes), VZV copy number was 1.9×107± 5.9×107 copy. Significant associations with the VZV amount was observed for facial skin eruption (OR; 4.1, 95% CI: 2.5- 6.5, P=0.000) and extraocular muscle paralysis (OR; 2.0, 95% CI: 1.2- 3.4, P=0.007), followed by IOP elevation, dendritic lesion, and mutton-fat keratic precipitate. VZV amount and facial skin eruption showed highest diagnostic accuracy calculated as area under the curve (AUC) of 0.92 and 0.96, respectively. The mean disease duration of VZV-associated keratitis was 108 days. Higher amount of VZV (per log) and the presence of iridocyclitis significantly prolonged the duration of active disease with hazard ratio of 0.75 (P=0.003) and 0.18 (P=0.002).

Conclusions :
Quantification of VZV genome is effective for predicting the persistence of active disease as well as diagnosis of VZV keratitis.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×